Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM

Hormone and Metabolic Research

Volumn 29, Issue 9, 1997, Pages 436-439

  Hubinger A ^a,b   Knode, O ^a   Susanto, F ^a   Reinauer, H ^a   Cries, F A ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Carnitine acyltransferase; Cori cycle; Etomoxir; Insulin resistance

Indexed keywords

ENZYME INHIBITOR; ETOMOXIR;

ADULT; AGED; ARTICLE; CALORIMETRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENERGY EXPENDITURE; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE OXIDATION; GLUCOSE UTILIZATION; HUMAN; INSULIN SENSITIVITY; LIPID OXIDATION; MALE; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

FELIS CATUS;

EID: 0030699261     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979072     Document Type: Article

References (22)

1. Collier, G. R.. K. Trainanedes, S. L Macaulay, K. O.'Dea: Effect of fatty acid oxidation inhibition on glucose metabolism in diabetic rats. Horm Metabol Res 25: 9-12 (1993)
2. DelPrato, S., R. C. Bonadonna, E. Bonora, C. Gulli, A. Solini, M. Shank, R. A. DeFronzo: Characterization of cellular defects of insulin action in type 2 diabetes mellitus.J Clin Invest 91:484-494 (1993)
3. Ebeling, P., V. A. Koivisto: Non estified fatty acids regulate lipid and glucose oxidation and glycogen synthesis in healthy man. Diabetologia 37: 2020-209 (1994)
4. AFelber,J. P., E. Ferrannini, A. Colay, H. U. Meyer, D. Thiebaud, B. Curchod. E. Maeder, E.Jegeter, R. A. DeFronzo: Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type 2 diabetes. Diabetes 36:1341 -1350 (1987)
5. Ferrannini, £.: The theoretical bases of indirect calorimetry: A review. Metabolism 37: 287-301 (1988)
6. Foley,J. E.: Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus. Diab Care 15: 773-784 (1992)
7. Froze, F., D. V. Donner, A. L Swislocki, Y. A. Chiou, Y. D. Chen. C. M. Reaven: Ambient plasma free fatty acid concentrations in non-insulin-dependent diabetes mellitus: evidence for insulin resistance. Metabolism 61: 807-811 (1985)
8. Croop, L C, C. Saloranta, M. Schank, R. C. Bonadonna. E. Ferrannini, R. A. DeFronzo: The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 72: 96-107 (1991)
9. Colay, A., A. L Swislocki, Y. D. Chen, G. M. Reaven: Relationship between plasma free fatty acid concentration, endogenous glucose production and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism 36: 692-696 (1987)
10. Hübinger. A.. C. Weikert. H. P. 0. Wolf, F. A. Cries: The effect of etomoxir on insulin sensitivity in type 2 diabetic patients. Horm Metabol Res 24:115-118 (1992)
11. Kruszynska. Y. T., H. S. A. Sherrat: The effects of 2-[6-(4-chorophenoxy)hexyI]oxirance-2-carboxyl (etomoxir) on glucose turnover in fasted rats. BiochemSoc Trans 14: 699-700(1986)
12. uNikkilä, E. A.: Plasma lipid and lipoprotein abnormalities in diabetes. In: Diabetes and Heart Diseasejarrat, E.J., Ed. Amsterdam, Elsevier 133-167 (1984)
13. Rändle, O.J., N. C. Hales, P. B. Garland, E. A. Newsholme: The glucose-fatty acid cycle. Lancet 1: 785-789 (1963)
14. Reinauer, H., F. A. Cries, A. Hübinger, 0. Knode, K. Severing, F. Susanto: Determination of glucose turnover and glucose oxidation rates in man with stable isotope tracers. J Clin Chem Clin Biochem 28:505-511(1990)
15. Rennie, M.J.J. 0. Holloszy: Inhibition of glucose uptake and glycogenolysis by availability of oleate in well oxygen perfused skeletal muscle. BiochemJ 168:161 -170 (1977)
16. Rosen, P., H. Reinauer: Inhibition of carnitine palmitoyltransferase 1 by phenylalkyloxiranecarboxylic acid and its influence on lipolysis and glucose metabolism in isolated perfused heart of streptozotocin-diabetic rats. Metabolism 33:177-185 (1984)
17. Seyffert, W. A., L L Madison: Physiologic effect of metabolic fuels on carbohydrate metabolism. Diabetes 16: 765-776 (1967)
18. Taskinen, M. R., C. Bogardus, A. Kennedy, B. V. Howard: Multiple disturbances of free fatty acid metabolism in non-insulin dependent diabetes. Effect of oral hypoglycémie therapy.J Clin Invest 76:637-644(1985)
19. Wolf, H. P. 0., D. W. Engel: Decrease of fatty acid oxidation, ketogenesis and gluconeogenesis in isolated perfused rat liver by phenylalkyloxiranecarboxylate (B807-27) due to inhibition of CPTI (EC 2.3.1.21) Eur J Biochem 146: 369-373 (1985)
20. Wolf, H. P. 0., K. Eistetter, C. Ludwig: Phenylalkyloxiranecarboxylic acids, a new class of hypoglycémie substances: Hypoglycémie and hypoketoneamic effects of sodium 2-[5-(4-chIorophenyl)pentyI]-oxirane-2-carboxy!ate (B807-27) in fasted animals. Diabetologia 25: 204-207 (1988)
21. Wolf. H. P. 0., K. V. Brenner. The effect of etomoxir on glucose turnover and recycling with [1-14C], [3-3H] glucose tracer in pigs. Horm Metabol Res 20: 204-207 (1988)
22. Yki-Yärvinnen, H., 1. Pukakainen, V. A. Koivisto: Effects of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation.] ClinEndocrin Metab 72:1268-1277(1991)